Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma. (Q33918062)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

R Golfieri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

E Giampalma

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

R Cioni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

C Bartolozzi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

A D Breatta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

R Nani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

D Gasparini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

L Bolondi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

F Trevisani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

PRECISION ITALIA STUDY GROUP

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

language of work or name

English

0 references

publication date

17 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

255-264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma

20 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102934

Epidemiology of viral hepatitis and hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102934

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102934

Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102934

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102934

Treatment approach of hepatocellular carcinoma in Spain. Analysis of 705 patients from 62 centers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102934

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102934

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102934

Management of hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102934

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102934

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102934

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102934

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102934

When to stop a clinical trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102934

Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).

5 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.199

Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.199

Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.199

Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.199

Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.199

Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.199

Doxorubicin-eluting bead versus conventional TACE for unresectable hepatocellular carcinoma: a meta-analysis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102934

Role of additional angiography and chemoembolization in patients with hepatocellular carcinoma who achieved complete necrosis following transarterial chemoembolization

29 October 2018

1 reference

12 December 2020

Indexes and boundaries for "quantitative significance" in statistical decisions

1 reference

12 December 2020

Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response

1 reference

12 December 2020

Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)

1 reference

12 December 2020

Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma

1 reference

12 December 2020

Can we trust in trials stopped early for benefit?

1 reference

12 December 2020

Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2014.199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

PubMed publication ID

24937669

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24937669%20AND%20SRC:MED&resulttype=core&format=json